271 related articles for article (PubMed ID: 27869830)
1. Inactivation of Capicua drives cancer metastasis.
Okimoto RA; Breitenbuecher F; Olivas VR; Wu W; Gini B; Hofree M; Asthana S; Hrustanovic G; Flanagan J; Tulpule A; Blakely CM; Haringsma HJ; Simmons AD; Gowen K; Suh J; Miller VA; Ali S; Schuler M; Bivona TG
Nat Genet; 2017 Jan; 49(1):87-96. PubMed ID: 27869830
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.
Simón-Carrasco L; Graña O; Salmón M; Jacob HKC; Gutierrez A; Jiménez G; Drosten M; Barbacid M
Genes Dev; 2017 Jul; 31(14):1456-1468. PubMed ID: 28827401
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Nov; 29(11):1324-1334. PubMed ID: 27443513
[TBL] [Abstract][Full Text] [Related]
4. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis.
Kim E; Kim D; Lee JS; Yoe J; Park J; Kim CJ; Jeong D; Kim S; Lee Y
Hepatology; 2018 Jun; 67(6):2287-2301. PubMed ID: 29251790
[TBL] [Abstract][Full Text] [Related]
5. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
Liu CY; Yu T; Huang Y; Cui L; Hong W
J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
[TBL] [Abstract][Full Text] [Related]
6. ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions.
Le Guellec S; Velasco V; Pérot G; Watson S; Tirode F; Coindre JM
Mod Pathol; 2016 Dec; 29(12):1523-1531. PubMed ID: 27562494
[TBL] [Abstract][Full Text] [Related]
7. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.
Aytes A; Mitrofanova A; Kinkade CW; Lefebvre C; Lei M; Phelan V; LeKaye HC; Koutcher JA; Cardiff RD; Califano A; Shen MM; Abate-Shen C
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):E3506-15. PubMed ID: 23918374
[TBL] [Abstract][Full Text] [Related]
8. ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally.
Wang Y; Ding X; Liu B; Li M; Chang Y; Shen H; Xie SM; Xing L; Li Y
Mol Carcinog; 2020 Jan; 59(1):73-86. PubMed ID: 31670855
[TBL] [Abstract][Full Text] [Related]
9. ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.
Tyagi N; Deshmukh SK; Srivastava SK; Azim S; Ahmad A; Al-Ghadhban A; Singh AP; Carter JE; Wang B; Singh S
Mol Cancer Res; 2018 Feb; 16(2):187-196. PubMed ID: 29117940
[TBL] [Abstract][Full Text] [Related]
10. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
[TBL] [Abstract][Full Text] [Related]
11. Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines.
Sloan KA; Marquez HA; Li J; Cao Y; Hinds A; O'Hara CJ; Kathuria S; Ramirez MI; Williams MC; Kathuria H
Carcinogenesis; 2009 Aug; 30(8):1433-42. PubMed ID: 19483189
[TBL] [Abstract][Full Text] [Related]
12. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction.
Euhus D; Bu D; Xie XJ; Sarode V; Ashfaq R; Hunt K; Xia W; O'Shaughnessy J; Grant M; Arun B; Dooley W; Miller A; Flockhart D; Lewis C
Cancer Prev Res (Phila); 2011 Nov; 4(11):1852-62. PubMed ID: 21778330
[TBL] [Abstract][Full Text] [Related]
14. NANOG gene expression is regulated by the ETS transcription factor ETV4 in human embryonic carcinoma NCCIT cells.
Park SW; Do HJ; Choi W; Song H; Chung HJ; Kim JH
Biochem Biophys Res Commun; 2017 Jun; 487(3):532-538. PubMed ID: 28412366
[TBL] [Abstract][Full Text] [Related]
15. ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.
Oh S; Shin S; Janknecht R
Biochim Biophys Acta; 2012 Aug; 1826(1):1-12. PubMed ID: 22425584
[TBL] [Abstract][Full Text] [Related]
16. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.
Zhang B; Tao F; Zhang H
Mol Med Rep; 2018 Apr; 17(4):4899-4908. PubMed ID: 29393472
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-2 promotes tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK-MAPK-ETV4-MMP-E-cadherin deregulation.
Fung TM; Ng KY; Tong M; Chen JN; Chai S; Chan KT; Law S; Lee NP; Choi MY; Li B; Cheung AL; Tsao SW; Qin YR; Guan XY; Chan KW; Ma S
J Pathol; 2016 Jul; 239(3):309-19. PubMed ID: 27063000
[TBL] [Abstract][Full Text] [Related]
19. Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levels.
Hsu MK; Wu IC; Cheng CC; Su JL; Hsieh CH; Lin YS; Chen FC
Oncotarget; 2015 Oct; 6(30):28755-73. PubMed ID: 26356813
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulatory networks in human lung adenocarcinoma.
Meng X; Lu P; Bai H; Xiao P; Fan Q
Mol Med Rep; 2012 Nov; 6(5):961-6. PubMed ID: 22895549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
